Domain Therapeutics SA of France has raised €2 million in funding from new and existing investors in order to finance its move from contract manufacturing to therapeutic drug development in the area of G-Protein Coupled Receptors (GPCRs) ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
